1 Vissers MN, Zock PL & Katan MB (2004) Bioavailability and antioxidant effects of olive oil phenols in humans: a review. Eur J Clin Nutr 58, 955–965.
2 Cooper KA, Chopra M & Thurnham D (2004) Wine polyphenols and promotion of cardiac health. Nutr Res Rev 17, 111–129.
3 Cabrera C, Artacho R & Gimenez R (2006) Beneficial effects of green tea – a review. J Am Coll Nutr 25, 79–99.
4 Engler MB & Engler MM (2006) The emerging role of flavonoid-rich cocoa and chocolate in cardiovascular health and disease. Nutr Rev 64, 109–118.
5 Ding EL, Hutfless SM, Ding X & Girotra S (2006) Chocolate and prevention of cardiovascular disease: a systematic review. Nutr Metab (Lond) 3, 2.
6 Wollgast J & Anklam E (2000) Review on polyphenols in Theobroma cacao: changes in composition during the manufacture of chocolate and methodology for identification and quantification. Food Res Int 33, 423–447.
7 Cook N & Samman S (1996) Flavonoids – chemistry, metabolism, cardioprotective effects, and dietary sources. J Nutr Biochem 7, 66–76.
8 Zhu QY, Huang Y & Chen ZY (2000) Interaction between flavonoids and alpha-tocopherol in human low density lipoprotein. J Nutr Biochem 11, 14–21.
10 Vinson JA, Proch J, Bose P, Muchler S, Taffera P, Shuta D, Samman N & Agbor GA (2006) Chocolate is a powerful ex vivo and in vivo antioxidant, an antiatherosclerotic agent in an animal model, and a significant contributor to antioxidants in the European and American diets. J Agric Food Chem 54, 8071–8076.
11 Waterhouse AL, Shirley JR & Donovan JL (1996) Antioxidants in chocolate. Lancet 348, 834.
12 Arts IC, Hollman PC & Kromhout D (1999) Chocolate as a source of tea flavonoids. Lancet 354, 488.
13 Richelle M, Tavazzi I, Enslen M & Offord EA (1999) Plasma kinetics in man of epicatechin from black chocolate. Eur J Clin Nutr 53, 22–26.
14 Rein D, Paglieroni TG, Wun T, Pearson DA, Schmitz HH, Gosselin R & Keen CL (2000) Cocoa inhibits platelet activation and function. Am J Clin Nutr 72, 30–35.
15 Rein D, Lotito S, Holt RR, Keen CL, Schmitz HH & Fraga CG (2000) Epicatechin in human plasma: in vivo determination and effect of chocolate consumption on plasma oxidation status. J Nutr 130, 2109S–2114S.
16 Kondo K, Matsumoto A, Kurata H, Tanahashi H, Koda H, Amachi T & Itakura H (1994) Inhibition of oxidation of low-density lipoprotein with red wine. Lancet 344, 1152.
17 Fuhrman B, Lavy A & Aviram M (1995) Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr 61, 549–554.
18 Whitehead TP, Robinson D, Allaway S, Syms J & Hale A (1995) Effect of red wine ingestion on the antioxidant capacity of serum. Clin Chem 41, 32–35.
19 Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP & Goldberg DM (1996) Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta 246, 163–182.
20 Rein D, Paglieroni TG, Pearson DA, Wun T, Schmitz HH, Gosselin R & Keen CL (2000) Cocoa and wine polyphenols modulate platelet activation and function. J Nutr 130, 2120S–2126S.
21 Buijsse B, Feskens EJ, Kok FJ & Kromhout D (2006) Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen Elderly Study. Arch Intern Med 166, 411–417.
22 Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA & Jacobs DR Jr (2007) Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 85, 895–909.
23 Francis ST, Head K, Morris PG & Macdonald IA (2006) The effect of flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young people. J Cardiovasc Pharmacol 47, Suppl. 2, S215–S220.
24 Ramljak D, Romanczyk LJ, Metheny-Barlow LJ, Thompson N, Knezevic V, Galperin M, Ramesh A & Dickson RB (2005) Pentameric procyanidin from Theobroma cacao selectively inhibits growth of human breast cancer cells. Mol Cancer Ther 4, 537–546.
25 Grassi D, Lippi C, Necozione S, Desideri G & Ferri C (2005) Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr 81, 611–614.
26 Holt RR, Lazarus SA, Sullards MC, Zhu QY, Schramm DD, Hammerstone JF, Fraga CG, Schmitz HH & Keen CL (2002) Procyanidin dimer B2 [epicatechin-(4beta-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am J Clin Nutr 76, 798–804.
27 Manach C, Williamson G, Morand C, Scalbert A & Remesy C (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81, 230S–242S.
28 Spencer JP, Schroeter H, Shenoy B, Srai SK, Debnam ES & Rice-Evans C (2001) Epicatechin is the primary bioavailable form of the procyanidin dimers B2 and B5 after transfer across the small intestine. Biochem Biophys Res Commun 285, 588–593.
29 Spencer JP, Schroeter H, Rechner AR & Rice-Evans C (2001) Bioavailability of flavan-3-ols and procyanidins: gastrointestinal tract influences and their relevance to bioactive forms in vivo. Antioxid Redox Signal 3, 1023–1039.
30 Schroeter H, Heiss C, Balzer , et al. (2006) ( − )-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 103, 1024–1029.
31 Gotti R, Furlanetto S, Pinzauti S & Cavrini V (2006) Analysis of catechins in Theobroma cacao beans by cyclodextrin-modified micellar electrokinetic chromatography. J Chromatogr A 1112, 345–352.
32 Donovan JL, Crespy V, Oliveira M, Cooper KA, Gibson BB & Williamson G (2006) (+)-Catechin is more bioavailable than ( − )-catechin: relevance to the bioavailability of catechin from cocoa. Free Radic Res 40, 1029–1034.
33 Donovan JL, Bell JR, Kasim-Karakas S, German JB, Walzem RL, Hansen RJ & Waterhouse AL (1999) Catechin is present as metabolites in human plasma after consumption of red wine. J Nutr 129, 1662–1668.
34 Holt RR, Schramm DD, Keen CL, Lazarus SA & Schmitz HH (2002) Chocolate consumption and platelet function. JAMA 287, 2212–2213.
35 Schindler TH, Hornig B, Buser PT, Olschewski M, Magosaki N, Pfisterer M, Nitzsche EU, Solzbach U & Just H (2003) Prognostic value of abnormal vasoreactivity of epicardial coronary arteries to sympathetic stimulation in patients with normal coronary angiograms. Arterioscler Thromb Vasc Biol 23, 495–501.
36 Vita JA (2005) Endothelial function and clinical outcome. Heart 91, 1278–1279.
37 Vlachopoulos C, Aznaouridis K, Alexopoulos N, Economou E, Andreadou I & Stefanadis C (2005) Effect of dark chocolate on arterial function in healthy individuals. Am J Hypertens 18, 785–791.
38 Hermann F, Spieker L, Ruschitzka F, et al. (2006) Dark chocolate improves endothelial and platelet function. Heart 92, 119–120.
39 Heiss C, Finis D, Kleinbongard P, Hoffmann A, Rassaf T, Kelm M & Sies H (2007) Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week. J Cardiovasc Pharmacol 49, 74–80.
40 Osakabe N, Baba S, Yasuda A, Iwamoto T, Kamiyama M, Takizawa T, Itakura H & Kondo K (2001) Daily cocoa intake reduces the susceptibility of low-density lipoprotein to oxidation as demonstrated in healthy human volunteers. Free Radic Res 34, 93–99.
41 Cooper KA, Campos Giménez E, Jiménez Alvarez D, Nagy K, Donovan JL & Williamson G (2007) Rapid reversed phase-ultra performance liquid chromatography analysis of the major cocoa polyphenols and inter-relationships of their concentrations in chocolate. J Agric Food Chem 55, 2841–2847.
42 Schramm DD, Wang JF, Holt RR, Ensunsa JL, Gonsalves JL, Lazarus SA, Schmitz HH, German JB & Keen CL (2001) Chocolate procyanidins decrease the leukotriene-prostacyclin ratio in humans and human aortic endothelial cells. Am J Clin Nutr 73, 36–40.
43 Karim M, McCormick K & Kappagoda CT (2000) Effects of cocoa extracts on endothelium-dependent relaxation. J Nutr 130, 2105S–2108S.
44 Mao T, Van de Water J, Keen CL, Schmitz HH & Gershwin ME (2000) Cocoa procyanidins and human cytokine transcription and secretion. J Nutr 130, 2093S–2099S.
45 Schewe T, Sadik C, Klotz LO, Yoshimoto T, Kuhn H & Sies H (2001) Polyphenols of cocoa: inhibition of mammalian 15-lipoxygenase. Biol Chem 382, 1687–1696.
46 Wan Y, Vinson JA, Etherton TD, Proch J, Lazarus SA & Kris-Etherton PM (2001) Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. Am J Clin Nutr 74, 596–602.
47 Kris-Etherton PM, Derr J, Mitchell DC, Mustad VA, Russell ME, McDonnell ET, Salabsky D & Pearson TA (1993) The role of fatty acid saturation on plasma lipids, lipoproteins, and apolipoproteins: I. Effects of whole food diets high in cocoa butter, olive oil, soybean oil, dairy butter, and milk chocolate on the plasma lipids of young men. Metabolism 42, 121–129.
48 Kris-Etherton PM, Derr JA, Mustad VA, Seligson FH & Pearson TA (1994) Effects of a milk chocolate bar per day substituted for a high-carbohydrate snack in young men on an NCEP/AHA Step 1 Diet. Am J Clin Nutr 60, 1037S–1042S.
49 Schramm DD, Karim M, Schrader HR, Holt RR, Kirkpatrick NJ, Polagruto JA, Ensunsa JL, Schmitz HH & Keen CL (2003) Food effects on the absorption and pharmacokinetics of cocoa flavanols. Life Sci 73, 857–869.
50 Bayard V, Chamorro F, Motta J & Hollenberg NK (2007) Does flavanol intake influence mortality from nitric oxide-dependent processes? Ischemic heart disease, stroke, diabetes mellitus, and cancer in Panama. Int J Med Sci 4, 53–58.
51 Serafini M, Bugianesi R, Maiani G, Valtuena S, De Santis S & Crozier A (2003) Plasma antioxidants from chocolate – dark chocolate may offer its consumers health benefits the milk variety cannot match. Nature 424, 1013.
52 Schroeter H, Holt RR, Orozco TJ, Schmitz HH & Keen CL (2003) Nutrition: milk and absorption of dietary flavanols. Nature 426, 787–788.
53 Serafini M & Crozier A (2003) Nutrition – milk and absorption of dietary flavanols – reply. Nature 426, 788.
54 Wiswedel I, Hirsch D, Kropf S, Gruening M, Pfister E, Schewe T & Sies H (2004) Flavanol-rich cocoa drink lowers plasma F-2-isoprostane concentrations in humans. Free Radic Biol Med 37, 411–421.
55 Roura E, Andés-Lacueva C, Jauregui O, Badia E, Estruch R, Izquierdo-Pulido M & Lamuela-Raventos RM (2005) Rapid liquid chromatography tandem mass spectrometry assay to quantify plasma ( − )-epicatechin metabolites after ingestion of a standard portion of cocoa beverage in humans. J Agric Food Chem 53, 6190–6194.
56 Wang JF, Schramm DD, Holt RR, Ensunsa JL, Fraga CG, Schmitz HH & Keen CL (2000) A dose–response effect from chocolate consumption on plasma epicatechin and oxidative damage. J Nutr 130, 2115S–2119S.
57 Engler MB, Engler MM, Chen CY, et al. (2004) Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J Am Coll Nutr 23, 197–204.
58 Mursu J, Voutilainen S, Nurmi T, Rissanen TH, Virtanen JK, Kaikkonen J, Nyyssonen K & Salonen JT (2004) Dark chocolate consumption increases HDL cholesterol concentration and chocolate fatty acids may inhibit lipid peroxidation in healthy humans. Free Radic Biol Med 37, 1351–1359.
59 Heiss C, Kleinbongard P, Dejam A, Perre S, Schroeter H, Sies H & Kelm M (2005) Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J Am Coll Cardiol 46, 1276–1283.
60 Katan MB (2007) Does industry sponsorship undermine the integrity of nutrition research? PLoS Med 4, e6.
61 Usmani OS, Belsivi MG, Oatel HJ, Crispino N, Birrell MA, Korbonits M, Korbonits N & Barnes PJ (2004) Theobromine inhibits sensory nerve activation and cough. FASEB 19, 231–233.
62 Pearson DA, Paglieroni TG, Rein D, et al. (2002) The effects of flavanol-rich cocoa and aspirin on ex vivo platelet function. Thromb Res 106, 191–197.
63 Mathur S, Devaraj S, Grundy SM & Jialal I (2002) Cocoa products decrease low density lipoprotein oxidative susceptibility but do not affect biomarkers of inflammation in humans. J Nutr 132, 3663–3667.
64 Taubert D, Berkels R, Roesen R & Klaus W (2003) Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. JAMA 290, 1029–1030.
65 Murphy KJ, Chronopoulos AK, Singh I, Francis MA, Moriarty H, Pike MJ, Turner AH, Mann NJ & Sinclair AJ (2003) Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function. Am J Clin Nutr 77, 1466–1473.
66 Fisher ND, Hughes M, Gerhard-Herman M & Hollenberg NK (2003) Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens 21, 2281–2286.
67 Heiss C, Dejam A, Kleinbongard P, Schewe T, Sies H & Kelm M (2003) Vascular effects of cocoa rich in flavan-3-ols. JAMA 290, 1030–1031.
68 Zhu QY, Schramm DD, Gross HB, Holt RR, Kim SH, Yamaguchi T, Kwik-Uribe CL & Keen CL (2005) Influence of cocoa flavanols and procyanidins on free radical-induced human erythrocyte hemolysis. Clin Dev Immunol 12, 27–34.
69 Fraga CG, Actis-Goretta L, Ottaviani JI, Carrasquedo F, Lotito SB, Lazarus S, Schmitz HH & Keen CL (2005) Regular consumption of a flavanol-rich chocolate can improve oxidant stress in young soccer players. Clin Dev Immunol 12, 11–17.
70 Grassi D, Necozione S, Lippi C, Croce G, Valeri L, Pasqualetti P, Desideri G, Blumberg JB & Ferri C (2005) Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 46, 398–405.
71 Fisher NDL & Hollenberg NK (2006) Aging and vascular responses to flavanol-rich cocoa. J Hypertens 24, 1575–1580.
72 Kurlandsky SB & Stote KS (2006) Cardioprotective effects of chocolate and almond consumption in healthy women. Nutr Res 26, 509–516.